Daiwa Securities Group
PGNX

Daiwa Securities Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Daiwa Securities Group’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-533
Closed -$2K – 1264
2020
Q2 		$2K Hold
533
– – ﹤0.01% 1176
2020
Q1 		$2K Hold
533
– – ﹤0.01% 1178
2019
Q4 		$3K Hold
533
– – ﹤0.01% 1154
2019
Q3 		$3K Hold
533
– – ﹤0.01% 1115
2019
Q2 		$3K Buy
533
+145
+37% +$699 ﹤0.01% 1139
2019
Q1 		$2K Hold
388
– – ﹤0.01% 1151
2018
Q4 		$2K Hold
388
– – ﹤0.01% 1119
2018
Q3 		$2K Hold
388
– – ﹤0.01% 1137
2018
Q2 		$3K Hold
388
– – ﹤0.01% 1131
2018
Q1 		$3K Buy
+388
New +$2.58K ﹤0.01% 1111

Daiwa Securities Group's PGNX Position: Q3 2020 in Review

Daiwa Securities Group sold out of Progenics Pharmaceuticals Inc (PGNX) in Q3 2020, closing a stake of 533 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in PGNX in Q1 2018 and held it in 10 quarters. The position peaked at $3K in Q4 2019. 0 funds tracked by Wall St. Rank hold PGNX as of Q3 2020.

  • Daiwa Securities Group reported no remaining Progenics Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Daiwa Securities Group sold 533 Progenics Pharmaceuticals Inc shares in Q3 2020, an estimated $2K.
  • Daiwa Securities Group first reported a position in Progenics Pharmaceuticals Inc in Q1 2018 and held it in 10 quarters.
  • Daiwa Securities Group's Progenics Pharmaceuticals Inc position peaked at $3K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2020.

Based on Daiwa Securities Group's 13F filing for Q3 2020, filed 2 Nov 2020.